Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sheridan

Showing results (171-180 of 294) with videos related to

Pageof 30
Sort By:
The Medical Journal of Australia|January 1, 1990
Combination chemotherapy as single modality therapy for stage IE and IIE thyroid lymphomaP J Leedman, W P Sheridan, W F Downey, et al.
Acta Neurologica Scandinavica|February 1, 2020
Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological studyCallum R Smith, Breda Cullen, Matthew P Sheridan, et al.
Biophysical Journal|September 1, 1985
Molecular dynamics of myoglobin at 298 degrees K. Results from a 300-ps computer simulationR M Levy, R P Sheridan, J W Keepers, et al.
Molecules (Basel, Switzerland)|October 1, 2016
Mining Chromatographic Enantioseparation Data Using Matched Molecular Pair AnalysisRobert P Sheridan, Patrick Piras, Edward C Sherer, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 19, 2010
Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trialE J Boyko, H C Gerstein, V Mohan, et al.
Cell and Tissue Research|August 18, 1975
Corticoid uptake by the paraventricular nucleus in the hypothalamus of the duck, Anas platyrhynchosJ H Abel, D Takemoto, D Hoffman, et al.
Blood|April 1, 1980
Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cellsM A Moore, H E Broxmeyer, A P Sheridan, et al.
Journal of Medicinal Chemistry|April 1, 1988
Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structureR L DesJarlais, R P Sheridan, G L Seibel, et al.
The Journal of Rheumatology|April 1, 1989
Protective HLA-DR phenotypes in rheumatoid arthritisB A Larsen, C A Alderdice, D Hawkins, et al.
American Journal of Hematology|August 6, 1998
Biologic and clinical significance of CD7 expression in acute myeloid leukemiaA Saxena, D P Sheridan, R T Card, et al.
Pageof 30

Showing results (171-180 of 294) with videos related to

Sort By:
Pageof 30
The Medical Journal of Australia|January 1, 1990
Combination chemotherapy as single modality therapy for stage IE and IIE thyroid lymphomaP J Leedman, W P Sheridan, W F Downey, et al.
Acta Neurologica Scandinavica|February 1, 2020
Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological studyCallum R Smith, Breda Cullen, Matthew P Sheridan, et al.
Biophysical Journal|September 1, 1985
Molecular dynamics of myoglobin at 298 degrees K. Results from a 300-ps computer simulationR M Levy, R P Sheridan, J W Keepers, et al.
Molecules (Basel, Switzerland)|October 1, 2016
Mining Chromatographic Enantioseparation Data Using Matched Molecular Pair AnalysisRobert P Sheridan, Patrick Piras, Edward C Sherer, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 19, 2010
Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trialE J Boyko, H C Gerstein, V Mohan, et al.
Cell and Tissue Research|August 18, 1975
Corticoid uptake by the paraventricular nucleus in the hypothalamus of the duck, Anas platyrhynchosJ H Abel, D Takemoto, D Hoffman, et al.
Blood|April 1, 1980
Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cellsM A Moore, H E Broxmeyer, A P Sheridan, et al.
Journal of Medicinal Chemistry|April 1, 1988
Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structureR L DesJarlais, R P Sheridan, G L Seibel, et al.
The Journal of Rheumatology|April 1, 1989
Protective HLA-DR phenotypes in rheumatoid arthritisB A Larsen, C A Alderdice, D Hawkins, et al.
American Journal of Hematology|August 6, 1998
Biologic and clinical significance of CD7 expression in acute myeloid leukemiaA Saxena, D P Sheridan, R T Card, et al.
Pageof 30